Happiness Biotech Group PE Ratio 2019-2021 | HAPP

Current and historical p/e ratio for Happiness Biotech Group (HAPP) from 2019 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Happiness Biotech Group PE ratio as of September 23, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Happiness Biotech Group PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-09-23 0.98 inf
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.032B $0.071B
Happiness Biotech Group Limited is a nutraceutical and dietary supplements producer. It is focused on the research, development, manufacturing and marketing of products made from Chinese herbal extracts and other ingredients. Happiness Biotech Group Limited is based in NANPING, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71